Acinetobacter baumannii Bouvet and Grimont (ATCC® BAA-2888)

Genome Data Seal Click here to learn about our Enhanced Authentication Initiative

Strain Designations: 157286  /  Type Strain: no  /  Biosafety Level: 2

Permits and Restrictions

View Permits View Restrictions

Reports Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As Acinetobacter baumannii
Verified By Whole-genome Sequencing
Strain Designations 157286
Application Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols
Isolation Trachea
Isolation Date 2004
Geographic Source Singapore
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format frozen
Storage Conditions -80°C or colder
Preceptrol® no
Annotated Genes abeM
abeS
ADC
adeA
adeB
adeC
adeF
adeG
adeH
adeI
adeJ
adeK
adeL
adeN
adeR
adeS
ANT(3'')-Ia
ANT(3'')-II
baeR
baeS
cat
catB
dfrA
emrB
macA
macB
msbA
OXA-23
OXA-64
rlmN
sat2
soxR
tolC
Type Strain no
MIC Range Susceptible
Amikacin: ≤16 µg/mL
Colistin: ≤2 µg/mL
Tetracycline: ≤4 µg/mL


Resistant
Cefepime: ≥32 µg/mL
Ceftazidime: ≥32 µg/mL
Ceftriaxone: ≥64 µg/mL
Ciprofloxacin: ≥4 µg/mL
Doripenem: ≥8 µg/mL
Imipenem: ≥8 µg/mL
Levofloxacin: ≥8 µg/mL
Meropenem: ≥8 µg/mL
Piperacillin-tazobactam: ≥128/4 µg/mL


Comments This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.

Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 28th Edition.

Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor International Health Management Associates (IHMA), Inc.
Special Collection Global Priority Superbugs
Chain of Custody ATCC <-- International Health Management Associates (IHMA), Inc.
Isolation Trachea
Isolation Date 2004
Geographic Source Singapore
Patient Age 71
Patient Gender Male
References

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 28th Edition. Wayne, PA. M100, 2018.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • The Clinical Isolates Collection (CIC) products are distributed under the additional terms of the Addendum for CIC Materials. It is required that the Addendum be signed and returned to ATCC prior to shipment.
  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Restrictions
Restrictions

Products in the Global Priority Superbugs collection are distributed under the additional terms of the Addendum for Global Priority Superbugs Materials. It is required that the Addendum be signed and returned to ATCC prior to shipment.

FAQs
  1. Accessing genome sequencing data


    Date Updated: 9/30/2019

  2. Criteria for reference quality genomes


    Date Updated: 9/30/2019